연구성과로 돌아가기

2020 연구성과별 연구자 정보 (1053 / 2428)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Incidence and Distribution of Respiratory Microorganisms Causing Acute Respiratory Infections at the University Hospital of Korea Song, K. E. Song, KE 2 Kyungpook Natl Univ, Sch Med, Dept Clin Pathol, Daegu, South Korea leenanyoung70@gmail.com;
Incidence and Distribution of Respiratory Microorganisms Causing Acute Respiratory Infections at the University Hospital of Korea Lee, N. Y. Lee, NY 3 교신저자 Kyungpook Natl Univ, Dept Lab Med, Chilgok Hosp, 807 Hoguk Ro, Daegu 41404, South Korea HZM-0321-2023 lee, nan leenanyoung70@gmail.com;
Incidence and Distribution of Respiratory Microorganisms Causing Acute Respiratory Infections at the University Hospital of Korea Lee, N. Y. Lee, NY 3 교신저자 Kyungpook Natl Univ, Sch Med, Dept Clin Pathol, Daegu, South Korea HZM-0321-2023 lee, nan leenanyoung70@gmail.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Noureddin, Mazen Noureddin, M 1 Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Schattenberg, Joern M. Schattenberg, JM 2 Univ Med Ctr Mainz, Dept Med 1, Metab Liver Res Program, Mainz, Germany C-1301-2013 Schattenberg, Jörn marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Crespo, Javier Crespo, J 3 Marques de Valdecilla Univ Hosp, Gastroenterol & Hepatol Unit, Santander, Spain F-8698-2018 Aguirre-Crespo, Francisco marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Kurosaki, Masayuki Kurosaki, M 4 Japanese Red Cross Musashino Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo, Japan marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Chen, Chi-Yi Chen, CY 5 Chia Yi Christian Hosp, Chiayi, Taiwan marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Leroy, Vincent Leroy, V 6 Ctr Hosp Univ, Grenoble, France marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Abdelmalek, Manal Abdelmalek, M 7 Duke Univ, Durham, NC 27706 USA AAW-2203-2020 Abdelmalek, Manal marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Tak, Won Young Tak, WY 8 Kyungpook Natl Univ, Daegu, South Korea marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials George, Jacob George, J 9 Westmead Hosp, Sydney, NSW, Australia KDN-5645-2024 George, Jacob 0000-0002-6592-3215 George, Jacob marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials George, Jacob George, J 9 Univ Sydney, Sydney, NSW, Australia KDN-5645-2024 George, Jacob 0000-0002-6592-3215 George, Jacob marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Shankar, Arun Shankar, A 10 Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich, Norfolk, England C-4779-2009 Shanker, Arun marianne.camargo2@gilead.com;
Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials Ding, Dora Ding, D 11 Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA marianne.camargo2@gilead.com;
페이지 이동: